{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:46:22Z","timestamp":1790898382064,"version":"4.1.0"},"reference-count":54,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2025-0278_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Neurodegenerative disorders such as Alzheimer\u2019s disease (AD) are characterized by progressive neuronal degeneration, predominantly caused by the accumulation of amyloid-beta (A\u03b2) and neuroinflammatory processes. Hypoxia, characterized by diminished oxygen levels, intensifies these mechanisms by stimulating hypoxiainducible factor 1-alpha (HIF-1\u03b1), potentially enhancing BACE1 enzyme activity and resulting in increased A\u03b2 synthesis and render neurons especially susceptible to hypoxia, exacerbating disease progression. Existing therapies are constrained by inadequate medication distribution across the blood-brain barrier and associated adverse effects. This study aims to identify potential therapeutic agents targeting HIF-1\u03b1, VEGFA, BACE1 key molecules involved in AD by exploring neuroprotective effects of bioactive compounds like benzyl isothiocyanate (BITC), Aurantiamide Acetate (AA), and galantamine, with the goal of developing more effective, targeted treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0278_abs_003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used\n                      <jats:italic>in silico<\/jats:italic>\n                      screening, such as molecular docking and ADMET analysis, to assess the binding affinity, pharmacokinetics, and toxicity of potential inhibitors, followed by\n                      <jats:italic>in\u00a0vitro<\/jats:italic>\n                      testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0278_abs_004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results identified several compounds with strong binding affinities and favorable ADMET profiles as potential inhibitors of HIF-1\u03b1, VEGFA, BACE1 and experimental data support that hypoxia, via HIF-1\u03b1, upregulates BACE1, increasing A\u03b2 production and contributing to AD. Targeting these pathways may offer a multi-faceted approach to therapy, reducing neuroinflammation and amyloid pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0278_abs_005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In silico<\/jats:italic>\n                      screening of potential molecules across different pathogenic pathways in Alzheimer\u2019s disease shows promise in developing successful therapeutic methods and continued validation may result in more tailored and safer medicines that address underlying neurodegenerative pathways.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2025-0278","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:15:12Z","timestamp":1772295312000},"page":"71-85","source":"Crossref","is-referenced-by-count":2,"title":["<i>In silico<\/i>\n                    evaluation of bioactive compounds as potential inhibitors targeting HIF-1\u03b1\/VEGFA\/BACE1 pathway against Alzheimer\u2019s disease"],"prefix":"10.1515","volume":"23","author":[{"given":"Sakshi","family":"Rai","sequence":"first","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Bhopal , Madhya Pradesh , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman Kumar","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Bhopal , Madhya Pradesh , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhes","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Bhopal , Madhya Pradesh , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026051215162684232_j_jcim-2025-0278_ref_001","doi-asserted-by":"crossref","unstructured":"Jennekens, FGI. A short history of the notion of neurodegenerative disease. J\u00a0Hist Neurosci 2014;23:85\u201394. https:\/\/doi.org\/10.1080\/0964704x.2013.809297.","DOI":"10.1080\/0964704X.2013.809297"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_002","doi-asserted-by":"crossref","unstructured":"Przedborski, S, Vila, M, Jackson-Lewis, V. Series introduction: neurodegeneration: what is it and where are we? J\u00a0Clin Investig 2003;111:3\u201310. https:\/\/doi.org\/10.1172\/jci17522.","DOI":"10.1172\/JCI200317522"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_055","doi-asserted-by":"crossref","unstructured":"Kim, S, Kim, DK, Jeong, S, Lee, J. The common cellular events in the neurodegenerative diseases and the associated role of endoplasmic reticulum stress. Int J Mol Sci 2022;23:5894. https:\/\/doi.org\/10.3390\/ijms23115894.","DOI":"10.3390\/ijms23115894"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_004","doi-asserted-by":"crossref","unstructured":"Yang, Y, Wang, Y, Jiang, X, Mi, J, Ge, D, Tong, Y, et al.. Modified Ce\/Zr-MOF nanoparticles loaded with curcumin for alzheimer\u2019s disease via multifunctional modulation. Int J N Innovat 2024;19:9943\u201359. https:\/\/doi.org\/10.2147\/ijn.s479242.","DOI":"10.2147\/IJN.S479242"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_005","doi-asserted-by":"crossref","unstructured":"Thies, W, Bleiler, L. 2012 Alzheimer\u2019s disease facts and figures Alzheimer\u2019s association. Alzheimer S & Dementia. 2012;8:131\u201368. https:\/\/doi.org\/10.1016\/j.jalz.2012.02.001","DOI":"10.1016\/j.jalz.2012.02.001"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_006","doi-asserted-by":"crossref","unstructured":"Bekris, LM, Yu, CE, Bird, TD, Tsuang, DW. Review article: genetics of Alzheimer disease. J\u00a0Geriatr Psychiatr Neurol 2010;23:213\u201327. https:\/\/doi.org\/10.1177\/0891988710383571.","DOI":"10.1177\/0891988710383571"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_007","doi-asserted-by":"crossref","unstructured":"Pardridge, WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2004;2:3\u201314. https:\/\/doi.org\/10.1602\/neurorx.2.1.3.","DOI":"10.1602\/neurorx.2.1.3"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_008","doi-asserted-by":"crossref","unstructured":"Mitroshina, EV, Savyuk, MO, Ponimaskin, E, Vedunova, MV. Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease. Front Cell Dev Biol 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.703084.","DOI":"10.3389\/fcell.2021.703084"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_009","doi-asserted-by":"crossref","unstructured":"Citron, M. Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov 2010;9:387\u201398. https:\/\/doi.org\/10.1038\/nrd2896.","DOI":"10.1038\/nrd2896"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_010","doi-asserted-by":"crossref","unstructured":"Stacey, BS, Hoiland, RL, Caldwell, HG, Howe, CA, Vermeulen, T, Tymko, MM, et al.. Lifelong exposure to high\u2010altitude hypoxia in humans is associated with improved redox homeostasis and structural\u2013functional adaptations of the neurovascular unit. J\u00a0Physiol 2023;601:1095\u2013120. https:\/\/doi.org\/10.1113\/jp283362.","DOI":"10.1113\/JP283362"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_011","doi-asserted-by":"crossref","unstructured":"T\u00f6nnies, E, Trushina, E. Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J\u00a0Alzheimers Dis 2017;57:1105\u201321. https:\/\/doi.org\/10.3233\/jad-161088.","DOI":"10.3233\/JAD-161088"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_012","doi-asserted-by":"crossref","unstructured":"Tao, B, Gong, W, Xu, C, Ma, Z, Mei, J, Chen, M. The relationship between hypoxia and Alzheimer\u2019s disease: an updated review. Front Aging Neurosci 2024;16. https:\/\/doi.org\/10.3389\/fnagi.2024.1402774.","DOI":"10.3389\/fnagi.2024.1402774"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_013","doi-asserted-by":"crossref","unstructured":"Coimbra, JRM, Marques, DFF, Baptista, SJ, Pereira, CMF, Moreira, PI, Dinis, TCP, et al.. Highlights in BACE1 inhibitors for Alzheimer\u2019s disease treatment. Front Chem 2018;6. https:\/\/doi.org\/10.3389\/fchem.2018.00178.","DOI":"10.3389\/fchem.2018.00178"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_014","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Trejo, SS, G\u00f3mez-Sierra, T, Eugenio-P\u00e9rez, D, Medina-Campos, ON, Pedraza-Chaverri, J. Protective effect of curcumin on D-Galactose-Induced senescence and oxidative stress in LLC-PK1 and HK-2 cells. Antioxidants 2024;13:415. https:\/\/doi.org\/10.3390\/antiox13040415.","DOI":"10.3390\/antiox13040415"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_015","doi-asserted-by":"crossref","unstructured":"Masarkar, N, Pal, M, Roy, M, Yadav, AK, Pandya, B, Lokhande, S, et al.. In-silico screening of bioactive compounds of Moringa oleifera as potential inhibitors targeting HIF-1\u03b1\/VEGF\/GLUT-1 pathway against breast cancer. J Compl Integr Med 2024;22:149\u201364. https:\/\/doi.org\/10.1515\/jcim-2024-0176.","DOI":"10.1515\/jcim-2024-0176"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_016","doi-asserted-by":"crossref","unstructured":"Lim, AWY, Schneider, L, Loy, C. Galantamine for dementia due to Alzheimer\u2019s disease and mild cognitive impairment. Cochrane Database Syst Rev 2024;11:CD001747. https:\/\/doi.org\/10.1002\/14651858.CD001747.","DOI":"10.1002\/14651858.CD001747.pub4"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_017","doi-asserted-by":"crossref","unstructured":"Daniel, RGM. In silico methods for the study of the interactions between drugs and their protein targets. Mexican J Medi Res ICSA 2024;12:67\u201371. https:\/\/doi.org\/10.29057\/mjmr.v12i24.12393.","DOI":"10.29057\/mjmr.v12i24.12393"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_018","doi-asserted-by":"crossref","unstructured":"Adebambo, K, Ojoh, O. In Silico investigation of novel compounds as inhibitors of acetylcholinesterase enzyme for the treatment of Alzheimer\u2019s diseases. Int J Alzheimers Dis 2024;2024:1\u201319. https:\/\/doi.org\/10.1155\/2024\/2988685.","DOI":"10.1155\/2024\/2988685"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_019","doi-asserted-by":"crossref","unstructured":"Kumar, M, Sharma, S, Tuli, HS, Parkash, V. Ferrocenyl substituted pyrazoles, synthesis via novel route, spectral investigations and their biological studies. Orient J Chem 2019;35:863\u20139. https:\/\/doi.org\/10.13005\/ojc\/350250.","DOI":"10.13005\/ojc\/350250"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_020","doi-asserted-by":"crossref","unstructured":"Agu, PC, Afiukwa, CA, Orji, OU, Ezeh, EM, Ofoke, IH, Ogbu, CO, et al.. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep 2023;13. https:\/\/doi.org\/10.1038\/s41598-023-40160-2.","DOI":"10.1038\/s41598-023-40160-2"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_021","doi-asserted-by":"crossref","unstructured":"Veber, DF, Johnson, SR, Cheng, HY, Smith, BR, Ward, KW, Kopple, KD, et al.. Molecular properties that influence the oral bioavailability of drug candidates. J\u00a0Med Chem 2002;45:2615\u201323. https:\/\/doi.org\/10.1021\/jm020017n.","DOI":"10.1021\/jm020017n"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_022","doi-asserted-by":"crossref","unstructured":"Di, L, Kerns, E, Carter, G. Drug-like property concepts in pharmaceutical design. Curr Pharm Des 2009;15:2184\u201394. https:\/\/doi.org\/10.2174\/138161209788682479.","DOI":"10.2174\/138161209788682479"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_023","doi-asserted-by":"crossref","unstructured":"Chedik, L, Baybekov, S, Cosnier, F, Marcou, G, Varnek, A, Champmartin, C, et al.. An update of skin permeability data based on a systematic review of recent research. Sci Data 2024;11. https:\/\/doi.org\/10.1038\/s41597-024-03026-4.","DOI":"10.1038\/s41597-024-03026-4"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_024","doi-asserted-by":"crossref","unstructured":"Rani, P, Mandal, P, Rajak, BK, Singh, DV. A review on dynamics of permeability-glycoprotein in efflux of chemotherapeutic drugs. Fronti Drug Disco 2024:4. https:\/\/doi.org\/10.3389\/fddsv.2024.1363364.","DOI":"10.3389\/fddsv.2024.1363364"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_025","doi-asserted-by":"crossref","unstructured":"Alsenan, S, Al-Turaiki, I, Hafez, A. A deep learning approach to predict blood-brain barrier permeability. PeerJ Comput Sci 2021;7. https:\/\/doi.org\/10.7717\/peerj-cs.515.","DOI":"10.7717\/peerj-cs.515"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_026","doi-asserted-by":"crossref","unstructured":"Zhao, M, Ma, J, Li, M, Zhang, Y, Jiang, B, Zhao, X, et al.. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci 2021;22. https:\/\/doi.org\/10.3390\/ijms222312808.","DOI":"10.3390\/ijms222312808"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_027","doi-asserted-by":"crossref","unstructured":"Kido, Y, Matsson, P, Giacomini, KM. Profiling of a prescription drug library for potential renal drug\u2013drug interactions mediated by the organic cation transporter 2. J\u00a0Med Chem 2011;54:4548\u201358. https:\/\/doi.org\/10.1021\/jm2001629.","DOI":"10.1021\/jm2001629"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_028","doi-asserted-by":"crossref","unstructured":"El-Sayed, NNE, Almaneai, NM, Bacha, AB, El-Ashrey, MK, Al-Zaben, MI, Almarhoon, ZM, et al.. Biological evaluation, molecular docking analyses, and ADME profiling of certain new quinazolinones as anti-colorectal agents. ACS Omega 2022;7:18443\u201358. https:\/\/doi.org\/10.1021\/acsomega.2c00812.","DOI":"10.1021\/acsomega.2c00812"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_029","doi-asserted-by":"crossref","unstructured":"Giacomini, KM, Huang, SM, Tweedie, DJ, Benet, LZ, Brouwer, KLR, Chu, X, et al.. Membrane transporters in drug development. Nat Rev Drug Discov 2010;9:215\u201336. https:\/\/doi.org\/10.1038\/nrd3028.","DOI":"10.1038\/nrd3028"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_030","doi-asserted-by":"crossref","unstructured":"Clemens, DL, Duryee, MJ, Hall, JH, Thiele, GM, Mikuls, TR, Klassen, LW, et al.. Relevance of the antioxidant properties of methotrexate and doxycycline to their treatment of cardiovascular disease. Pharmacol Therapeut 2019;205. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107413.","DOI":"10.1016\/j.pharmthera.2019.107413"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_031","doi-asserted-by":"crossref","unstructured":"Montilla-Garc\u00eda, \u00c1, Tejada, M\u00c1, Ruiz-Cantero, MC, Bravo-Caparr\u00f3s, I, Yeste, S, Zamanillo, D, et al.. Modulation by Sigma-1 receptor of morphine analgesia and tolerance: nociceptive pain, tactile allodynia and grip strength deficits during joint inflammation. Front Pharmacol 2019;10. https:\/\/doi.org\/10.3389\/fphar.2019.00136.","DOI":"10.3389\/fphar.2019.00136"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_032","doi-asserted-by":"crossref","unstructured":"Huang, Q, Wu, W, Wen, Y, Lu, S, Zhao, C. Potential therapeutic natural compounds for the treatment of Alzheimer\u2019s disease. Phytomedicine 2024;132. https:\/\/doi.org\/10.1016\/j.phymed.2024.155822.","DOI":"10.1016\/j.phymed.2024.155822"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_033","doi-asserted-by":"crossref","unstructured":"Andrade, S, Ramalho, MJ, Loureiro, JA, Pereira, MDC. Natural compounds for Alzheimer\u2019s disease therapy: a systematic review of preclinical and clinical studies. Int J Mol Sci 2019;20:2313. https:\/\/doi.org\/10.3390\/ijms20092313.","DOI":"10.3390\/ijms20092313"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_034","doi-asserted-by":"crossref","unstructured":"Conaway, C, Yang, YM, Chung, FL. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metabol 2002;3:233\u201355. https:\/\/doi.org\/10.2174\/1389200023337496.","DOI":"10.2174\/1389200023337496"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_035","doi-asserted-by":"crossref","unstructured":"Api, AM, Belsito, D, Botelho, D, Bruze, M, Burton, GA, Buschmann, J, et al.. RIFM fragrance ingredient safety assessment, butyrophenone, cas registry number 495-40-9. Food Chem Toxicol 2018;118:S32\u201340. https:\/\/doi.org\/10.1016\/j.fct.2018.06.031.","DOI":"10.1016\/j.fct.2018.06.031"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_036","doi-asserted-by":"crossref","unstructured":"Xu, Q, Cheong, YK, He, SQ, Tiwari, V, Liu, J, Wang, Y, et al.. Suppression of spinal connexin 43 expression attenuates mechanical hypersensitivity in rats after an L5 spinal nerve injury. Neurosci Lett 2014;566:194\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2014.03.004.","DOI":"10.1016\/j.neulet.2014.03.004"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_037","doi-asserted-by":"crossref","unstructured":"Egan, WJ, Merz, KM, Baldwin, JJ. Prediction of drug absorption using multivariate statistics. J\u00a0Med Chem 2000;43:3867\u201377. https:\/\/doi.org\/10.1021\/jm000292e.","DOI":"10.1021\/jm000292e"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_038","doi-asserted-by":"crossref","unstructured":"Etxebeste-Mitxeltorena, M, Niza, E, Fajardo, CM, Gil, C, G\u00f3mez-G\u00f3mez, L, Martinez, A, et al.. Neuroprotective properties of exosomes and chitosan nanoparticles of tomafran, a bioengineered tomato enriched in crocins. Natur Produ Biopros 2024;14. https:\/\/doi.org\/10.1007\/s13659-023-00425-9.","DOI":"10.1007\/s13659-023-00425-9"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_039","doi-asserted-by":"crossref","unstructured":"Razay, G, Wilcock, GK. Galantamine in Alzheimer\u2019s disease. Expert Rev Neurother 2007;8:9\u201317. https:\/\/doi.org\/10.1586\/14737175.8.1.9.","DOI":"10.1586\/14737175.8.1.9"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_040","doi-asserted-by":"crossref","unstructured":"Pandey, S, Tiwari, AK, Nisar, KS, Nath, A. Physicochemical determinants of blood brain barrier penetrating molecules. Res J Pharm Technol 2025:1250\u20137. https:\/\/doi.org\/10.52711\/0974-360x.2025.00181.","DOI":"10.52711\/0974-360X.2025.00181"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_041","doi-asserted-by":"crossref","unstructured":"Gottesman, MM, Fojo, T, Bates, SE. Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat Rev Cancer 2002;2:48\u201358. https:\/\/doi.org\/10.1038\/nrc706.","DOI":"10.1038\/nrc706"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_042","doi-asserted-by":"crossref","unstructured":"Maelicke, A, Albuquerque, EX. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer\u2019s disease. Eur J Pharmacol 2000;393:165\u201370. https:\/\/doi.org\/10.1016\/s0014-2999(00)00093-5.","DOI":"10.1016\/S0014-2999(00)00093-5"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_043","doi-asserted-by":"crossref","unstructured":"Swanson, D, Block, R, Mousa, SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr 2012;3:1\u20137. https:\/\/doi.org\/10.3945\/an.111.000893.","DOI":"10.3945\/an.111.000893"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_044","doi-asserted-by":"crossref","unstructured":"Anand, P, Kunnumakkara, AB, Newman, RA, Aggarwal, BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807\u201318. https:\/\/doi.org\/10.1021\/mp700113r.","DOI":"10.1021\/mp700113r"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_045","doi-asserted-by":"crossref","unstructured":"Zhang, L, Rana, I, Shaffer, RM, Taioli, E, Sheppard, L. Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: a meta-analysis and supporting evidence. Mutat Res Rev Mutat Res 2019;781:186\u2013206. https:\/\/doi.org\/10.1016\/j.mrrev.2019.02.001.","DOI":"10.1016\/j.mrrev.2019.02.001"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_046","doi-asserted-by":"crossref","unstructured":"Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. Adv Drug Deliv Rev 2001;46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0.","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_047","doi-asserted-by":"crossref","unstructured":"Roe, SM, Prodromou, C, O\u2019Brien, R, Ladbury, JE, Piper, PW, Pearl, LH, et al.. Structural basis for inhibition of the HSP90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J\u00a0Med Chem 1999;42:260\u20136. https:\/\/doi.org\/10.1021\/jm980403y.","DOI":"10.1021\/jm980403y"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_054","doi-asserted-by":"crossref","unstructured":"Bleiziffer, P, Schaller, K, Riniker, S. Machine learning of partial charges derived from high-quality quantum-mechanical calculations. J\u00a0Chem Inf Model 2018;58:579\u201390. https:\/\/doi.org\/10.1021\/acs.jcim.7b00663.","DOI":"10.1021\/acs.jcim.7b00663"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_048","doi-asserted-by":"crossref","unstructured":"Daina, A, Michielin, O, Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7. https:\/\/doi.org\/10.1038\/srep42717.","DOI":"10.1038\/srep42717"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_049","doi-asserted-by":"crossref","unstructured":"Pires, DEV, Blundell, TL, Ascher, DB. PKCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J\u00a0Med Chem 2015;58:4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","DOI":"10.1021\/acs.jmedchem.5b00104"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_050","doi-asserted-by":"crossref","unstructured":"Bajda, M, Guzior, N, Ignasik, M, Malawska, B. Multi-target-directed ligands in Alzheimer\u2019s disease treatment. Curr Med Chem 2011;18:4949\u201375. https:\/\/doi.org\/10.2174\/092986711797535245.","DOI":"10.2174\/092986711797535245"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_051","doi-asserted-by":"crossref","unstructured":"Panagiotou, M, Papagiannopoulos, K, Rohling, JHT, Meijer, JH, Deboer, T. How old is your brain? slow-wave activity in non-rapid-eye-movement sleep as a marker of brain rejuvenation after long-term exercise in mice. Front Aging Neurosci 2018;10. https:\/\/doi.org\/10.3389\/fnagi.2018.00233.","DOI":"10.3389\/fnagi.2018.00233"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_052","doi-asserted-by":"crossref","unstructured":"Poulakis, K, Pereira, JB, Mecocci, P, Vellas, B, Tsolaki, M, K\u0142oszewska, I, et al.. Heterogeneous patterns of brain atrophy in Alzheimer\u2019s disease. Neurobiol Aging 2018;65:98\u2013108. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.01.009.","DOI":"10.1016\/j.neurobiolaging.2018.01.009"},{"key":"2026051215162684232_j_jcim-2025-0278_ref_053","doi-asserted-by":"crossref","unstructured":"Koh, JJ, Zou, H, Mukherjee, D, Lin, S, Lim, F, Tan, JK, et al.. Amphiphilic xanthones as a potent chemical entity of anti-mycobacterial agents with membrane-targeting properties. Eur J Med Chem 2016;123:684\u2013703. https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.068.","DOI":"10.1016\/j.ejmech.2016.07.068"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0278\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:32:29Z","timestamp":1778599949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0278\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,29]]},"published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1515\/jcim-2025-0278"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2025-0278","relation":{},"ISSN":["2194-6329","1553-3840"],"issn-type":[{"value":"2194-6329","type":"print"},{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}